An AI tool may be able to predict GVHD risk, prompting earlier treatment to prevent complications. Image credit: Victor Bordera/Stocksy
An AI-based tool may be able to predict the risk of developing chronic graft-versus-host disease (GVHD) and transplant-related death after stem cell or bone marrow transplant.